5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.58▲ | 2.54▲ | 2.54▲ | 2.50▲ | 2.63▼ |
MA10 | 2.54▲ | 2.52▲ | 2.52▲ | 2.48▲ | 2.79▼ |
MA20 | 2.52▲ | 2.51▲ | 2.51▲ | 2.60▼ | 2.84▼ |
MA50 | 2.67▼ | 2.68▼ | 2.69▼ | 2.78▼ | 2.89▼ |
MA100 | 2.72▼ | 2.79▼ | 2.83▼ | 2.82▼ | 2.24▲ |
MA200 | 2.84▼ | 2.86▼ | 2.87▼ | 2.80▼ | 3.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.022▲ | 0.020▲ | 0.020▲ | 0.011▲ | -0.060▼ |
RSI | 54.623▲ | 51.213▲ | 50.564▲ | 48.902▼ | 46.625▼ |
STOCH | 92.593▲ | 66.579 | 64.591 | 52.645 | 29.218 |
WILL %R | 0.000▲ | -10.526▲ | -10.526▲ | -39.286 | -68.519 |
CCI | 122.680▲ | 90.052 | 96.466 | 68.772 | -135.338▼ |
Wednesday, April 24, 2024 03:33 AM
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead ...
|
Tuesday, April 23, 2024 09:00 AM
General Mills, Inc. engages in the manufacture and marketing of branded consumer foods sold through retail stores. The firm operates through the following segments: North America Retail, Europe ...
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/04/24 | 2.59 | 2.60 | 2.59 | 2.60 | 7,388 |
25/04/24 | 2.49 | 2.55 | 2.49 | 2.53 | 7,052 |
24/04/24 | 2.54 | 2.54 | 2.40 | 2.45 | 8,474 |
23/04/24 | 2.5599 | 2.5599 | 2.4131 | 2.42 | 5,238 |
22/04/24 | 2.36 | 2.56 | 2.26 | 2.51 | 21,158 |
19/04/24 | 2.49 | 2.5412 | 2.37 | 2.39 | 21,009 |
18/04/24 | 2.545 | 2.61 | 2.45 | 2.49 | 17,421 |
17/04/24 | 2.39 | 2.635 | 2.39 | 2.60 | 40,806 |
16/04/24 | 2.36 | 2.41 | 2.2906 | 2.37 | 16,028 |
15/04/24 | 2.36 | 2.4161 | 2.29 | 2.39 | 28,638 |
|
|
||||
|
|
||||
|
|